The growing interest in AI/Machine learning across industries has naturally extended to the pharmaceutical industry and life science sectors. As companies increasingly start to use AI tools, understanding both the expectations of regulatory authorities, when and how these tools can be used in GxP settings and also learn smart usage where AI can create value for Life Science is becoming essential.
Join us for an insightful session on the intersection between AI, GxP and Quality Management with PharmaRelations’ experts: Kent Wiberg, Nordic Head of QA, Hossein Asgari, Head of QA Denmark, and Niels Buch Leander, Chief Digital Officer.
Webinar Details
📅 Date: Wednesday, January 19, 2027
🕓 Time: 15:00 – 15:45 CET (45 minutes)
📍 Location: Online
Register to the webinar
Agenda:
🔹When and how can we in LifeScience use AI/Machine learning in the process
of developing and manufacturing drugs?
🔹Content in regulations and guidelines, like EU GMP Annex 22
🔹When will the use of AI be considered as GxP activity?
🔹If the AI use is considered as GxP activity, what is the demands?
🔹How to get authorities approval for using AI tools in LifeScience?
🔹Smart examples when the use of AI actually can create value for LifeScience
The webinar is free to attend and open to all registered participants.
We look forward to a meaningful and engaging afternoon together!